Sensus Healthcare to Present at the 10th Annual LD Micro Main Event
LOS ANGELES, CA / ACCESSWIRE / November 27, 2017 / Sensus Healthcare, Inc. (SRTS), a medical device company specializing in the non-invasive treatment of non-melanoma skin cancers and keloids with superficial radiation therapy (SRT), announced today that it will be presenting at the 10th annual LD Micro Main Event on Tuesday, December 5 at 5:00 PM PST/ 8:00 PM EST at the Luxe Sunset Boulevard Hotel in Los Angeles, CA. Joe Sardano, Chairman and Chief Executive Officer of Sensus Healthcare, will be presenting, as well as meeting with investors.
The LD Micro Main Event is the largest independent conference for small/micro-cap companies and will feature 250 names presenting to an audience of over 1,000 attendees. In addition, there will be a variety of speakers/panelists discussing topics of interest to investors and issuers, along with coordinated evening events.
Mr. Sardano's presentation will be webcast live on the internet and can be accessed by visiting the Investor Relations section of the Company's website at www.sensushealthcare.com. Following the presentation, a replay of the webcast will be archived on Sensus Healthcare's website for a period of time.
View Sensus Healthcare' profile here: www.ldmicro.com/profile/SRTS
News Compliments of ACCESSWIRE.
About Sensus Healthcare
Sensus Healthcare, Inc. is a medical device company that is committed to providing non-invasive and cost-effective treatment for non-melanoma skin cancers and keloids. Sensus uses a proprietary low energy X-ray technology known as superficial radiotherapy (SRT), which is a result of over a decade of dedicated research and development. Sensus has successfully incorporated SRT therapy into its portfolio of treatment devices, the SRT-100™ and SRT-100 Vision™. To date, SRT technology has been used to effectively and safely treat oncological and non-oncological skin conditions in thousands of patients. For more information, visit http://www.sensushealthcare.com.
About LD Micro
LD Micro was founded in 2006 with the sole purpose of being an independent resource in the microcap space. What started out as a newsletter highlighting unique companies has transformed into several influential conferences annually.
In 2015, LDM launched the first pure microcap index (the LDMi) to exclusively provide intraday information on the entire sector.
For those interested in attending, please contact David Scher at david@ldmicro.com or visit www.ldmicro.com/events for more information.
Contact:
LHA Investor Relations
Kim Sutton Golodetz
(212) 838-3777
kgolodetz@lhai.com
SOURCE: Sensus Healthcare, Inc.
